Ctc Capital Management, LLC Summit Therapeutics Inc. Transaction History
Ctc Capital Management, LLC
- $47.2 Million
- Q1 2023
A detailed history of Ctc Capital Management, LLC transactions in Summit Therapeutics Inc. stock. As of the latest transaction made, Ctc Capital Management, LLC holds 10,100 shares of SMMT stock, worth $188,365. This represents 0.04% of its overall portfolio holdings.
Number of Shares
10,100Holding current value
$188,365% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding SMMT
# of Institutions
144Shares Held
65.8MCall Options Held
1.05MPut Options Held
1.02M-
Baker Bros. Advisors LP New York, NY23.2MShares$433 Million2.41% of portfolio
-
Vanguard Group Inc Valley Forge, PA8.82MShares$164 Million0.0% of portfolio
-
Black Rock Inc. New York, NY7.9MShares$147 Million0.0% of portfolio
-
State Street Corp Boston, MA4.12MShares$76.9 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA2.96MShares$55.3 Million0.0% of portfolio
About Summit Therapeutics Inc.
- Ticker SMMT
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 201,215,008
- Market Cap $3.75B
- Description
- Summit Therapeutics Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines to treat infectious diseases in the United States and Latin America. It conducts clinical programs focusing on Clostridioides difficile infection (CDI). The company's lead product candidate is ridinilazole, an orally administered small molecu...